CD4 and melanoma: Early clinical studies used [111In]In-oxine labelling of CD4+ T-cells to investigate the homing of CD4+ T-cells in Hodgkin’s lymphoma lesions with SPECT imaging, and accumulation of adoptively transferred tumor infiltrating lymphocytes, previously expanded ex vivo, in melanoma patients [77, 78].